{"id":"https://openalex.org/W2986369396","doi":"https://doi.org/10.1093/neuonc/noz175.386","title":"EXTH-55. TEMOZOLOMIDE-RESISTANT GLIOMA CELLS ARE SENSITIVE TO CHLOROETHYLATING NITROSOUREA COMPOUNDS IN COMBINATION WITH ATR INHIBITORS","display_name":"EXTH-55. TEMOZOLOMIDE-RESISTANT GLIOMA CELLS ARE SENSITIVE TO CHLOROETHYLATING NITROSOUREA COMPOUNDS IN COMBINATION WITH ATR INHIBITORS","publication_year":2019,"publication_date":"2019-11-01","ids":{"openalex":"https://openalex.org/W2986369396","doi":"https://doi.org/10.1093/neuonc/noz175.386","mag":"2986369396"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/noz175.386","doi":"https://doi.org/10.1093/neuonc/noz175.386","is_oa":false,"landing_page_url":"https://doi.org/10.1093/neuonc/noz175.386","pdf_url":null,"source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6847612","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102971334","display_name":"Christopher B. Jackson","orcid":"https://orcid.org/0000-0003-1792-6726","observed_orcids":["https://orcid.org/0000-0003-1792-6726"]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Jackson","raw_affiliation_strings":["Columbia University College of Physicians and Surgeons, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University College of Physicians and Surgeons, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037216709","display_name":"Aravind Kalathil","orcid":"https://orcid.org/0000-0002-6701-9529","observed_orcids":["https://orcid.org/0000-0002-6701-9529"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aravind Kalathil","raw_affiliation_strings":["Yale University, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale University, New Haven, CT, USA","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040738951","display_name":"Ranjit S. Bindra","orcid":"https://orcid.org/0000-0002-3255-0467","observed_orcids":["https://orcid.org/0000-0002-3255-0467"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ranjit Bindra","raw_affiliation_strings":["Yale University School of Medicine, New Haven, CT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale University School of Medicine, New Haven, CT, USA","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"21","issue":"Supplement_6","first_page":"vi94","last_page":"vi94"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9700000286102295},{"id":"https://openalex.org/keywords/temozolomide-resistance","display_name":"temozolomide resistance","score":0.9980000257492065},{"id":"https://openalex.org/keywords/atr-inhibitors","display_name":"ATR inhibitors","score":0.9039999842643738},{"id":"https://openalex.org/keywords/lomustine","display_name":"lomustine","score":0.9440000057220459},{"id":"https://openalex.org/keywords/mismatch-repair-deficiency","display_name":"mismatch repair deficiency","score":0.9629999995231628},{"id":"https://openalex.org/keywords/mgmt-promoter-methylation","display_name":"MGMT promoter methylation","score":0.9340000152587891},{"id":"https://openalex.org/keywords/alkylating-agents","display_name":"alkylating agents","score":0.8130000233650208},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.7239999771118164},{"id":"https://openalex.org/keywords/recurrent-glioblastoma","display_name":"recurrent glioblastoma","score":0.746999979019165},{"id":"https://openalex.org/keywords/radiosensitization","display_name":"radiosensitization","score":0.906000018119812},{"id":"https://openalex.org/keywords/o6-methylguanine-dna-methyltransferase","display_name":"O6-methylguanine-DNA methyltransferase","score":0.7509999871253967},{"id":"https://openalex.org/keywords/u251-cells","display_name":"U251 cells","score":0.7519999742507935}],"concepts":[{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.9269806146621704},{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.6817464232444763},{"id":"https://openalex.org/C91965660","wikidata":"https://www.wikidata.org/wiki/Q415875","display_name":"Methyltransferase","level":4,"score":0.6211661696434021},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6131802201271057},{"id":"https://openalex.org/C2776946711","wikidata":"https://www.wikidata.org/wiki/Q418311","display_name":"Nitrosourea","level":3,"score":0.5536407828330994},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.5177109241485596},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4457036554813385},{"id":"https://openalex.org/C33288867","wikidata":"https://www.wikidata.org/wiki/Q518328","display_name":"Methylation","level":3,"score":0.2964218854904175},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.22768506407737732},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.17095208168029785},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.16351613402366638},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.11065655946731567}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/neuonc/noz175.386","doi":"https://doi.org/10.1093/neuonc/noz175.386","is_oa":false,"landing_page_url":"https://doi.org/10.1093/neuonc/noz175.386","pdf_url":null,"source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6847612","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6847612","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:6847612","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6847612","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2973031058","https://openalex.org/W2747119573","https://openalex.org/W2900138777","https://openalex.org/W3216851449","https://openalex.org/W2896956819","https://openalex.org/W3111774333","https://openalex.org/W4223582144","https://openalex.org/W4404053050","https://openalex.org/W7148914330","https://openalex.org/W3183006133"],"abstract_inverted_index":{"Abstract":[0],"BACKGROUND":[1],"Despite":[2],"decades":[3],"of":[4,19,47,72,86,96,124,133,177,216,271,289],"research,":[5],"nearly":[6],"all":[7],"patients":[8],"with":[9,54,114,138,166,227,275],"glioblastoma":[10],"(GBM)":[11],"face":[12],"recurrent":[13,92,103,298],"disease.":[14],"Temozolomide":[15],"(TMZ),":[16],"the":[17,27,45,58,70,130,214,265,269],"drug":[18],"choice":[20],"for":[21,69],"GBM,":[22],"methylates":[23],"guanine":[24],"bases":[25],"at":[26,168],"O6":[28],"position":[29],"(O6meG).":[30],"These":[31],"lesions":[32,51],"are":[33,156,281],"normally":[34],"repaired":[35],"by":[36],"O6meG-methyltransferase":[37],"(MGMT).":[38],"When":[39],"MGMT":[40],"is":[41,64,82,99],"deficient":[42],"(e.g.":[43],"in":[44,91,102,118,140,164,187,194,213,238,257,264,297],"case":[46],"promoter":[48],"hypermethylation),":[49],"O6meG":[50],"generate":[52],"mispairs":[53],"thymine":[55],"and":[56,153,159,170,189,211,254,273,292],"activate":[57],"mismatch":[59],"repair":[60],"system":[61],"(MMR),":[62],"which":[63,155],"thought":[65],"to":[66,128,162,191,196,206,221],"be":[67],"critical":[68],"cytotoxicity":[71],"TMZ.":[73],"Numerous":[74],"studies":[75],"have":[76,295],"established":[77],"that":[78,89,111,136,181,225,286],"acquired":[79],"MMR":[80],"deficiency":[81],"a":[83],"common":[84,101],"mechanism":[85],"TMZ":[87,112,163,192,212],"resistance":[88,186],"emerges":[90],"GBM.":[93,104,299],"However,":[94],"reversion":[95],"MGMT-methylation":[97],"status":[98],"not":[100],"Recent":[105],"work":[106,263],"from":[107],"our":[108],"group":[109],"demonstrated":[110],"synergizes":[113],"ATR":[115],"inhibitors":[116],"(ATRi\u2019s)":[117],"MGMT-methylated":[119,158,259],"GBM":[120,149,242,260],"cells.":[121,243,261],"The":[122],"goal":[123],"this":[125],"project":[126],"was":[127,235],"identify":[129],"specific":[131],"types":[132],"alkylating":[134,231],"agents":[135,256],"synergize":[137],"ATRi\u2019s":[139,210,234,253,274,280],"an":[141,248],"MGMT-methylated,":[142,240],"MMR-deficient":[143,172,241],"molecular":[144],"context.":[145],"RESULTS":[146],"We":[147,179],"used":[148],"cell":[150],"lines":[151],"U251":[152,188],"LN229,":[154],"both":[157],"exquisitely":[160],"sensitive":[161],"combination":[165],"ATRi":[167],"baseline,":[169],"created":[171],"versions":[173],"through":[174],"stable":[175],"knockdown":[176,183],"MSH2.":[178],"determined":[180],"MSH2":[182,217],"conferred":[184],"remarkable":[185],"LN229":[190],"treatment":[193,226],"comparison":[195],"their":[197],"respective":[198],"MMR-proficient":[199],"counterparts.":[200],"In":[201,219],"addition,":[202],"we":[203,223,246,284],"were":[204],"unable":[205],"detect":[207],"synergy":[208],"between":[209,252],"setting":[215],"knockdown.":[218],"contrast":[220],"TMZ,":[222],"found":[224],"chloroethyl":[228],"nitrosourea":[229],"(CNU)":[230],"agents--including":[232],"lomustine--with":[233],"extremely":[236],"effective":[237],"killing":[239],"CONCLUSION":[244],"Here,":[245],"report":[247],"exquisite":[249],"synergistic":[250],"interaction":[251,270],"CNU":[255,272],"MMR-deficient,":[258],"Future":[262],"lab":[266],"will":[267],"examine":[268],"radiation":[276],"therapy":[277],"(RT).":[278],"Because":[279],"known":[282],"radiosensitizers,":[283],"believe":[285],"novel":[287],"combinations":[288],"ATRi\u2019s,":[290],"lomustine,":[291],"re-RT":[293],"may":[294],"promise":[296]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-11-22T00:00:00"}